Síndrome de las escleras azules. Estudio de una familia y revisión de la enfermedad

Referencias bibliográficas

  1. Smith R, Francis MJ, Houghton GR. The brittle bone syndrome. In: Osteogenesis Imperfecta. London: Butterworth. 1983.
  2. Torres Molina Alexander. Huesos de cristal. Presentación de un caso: de la eritropoyesis a la cardioprotección. MediSur [Internet]. 2010 Ago [citado 2013 Mar 09]; 8(4): 72-74. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2010000400011&lng=es.
  3. Brusin JH. Osteogenesis imperfecta. Radiol Technol. Jul-Aug 2008;79(6):535-48.
  4. Cole WG. Bone, cartilage and fibrous tissue disorders. In: Benson MKD, Fixsen JA, MacNicol MF, Parch K, eds. Children’s Orthopaedics. 2002: 67-92.
  5. Baujat G, Lebre AS, Cormier-Daire V, Le Merrer M. Osteogenesis imperfecta, diagnosis information (clinical and genetic classification). Arch Pediatr. Jun 2008;15(5):789-91.
  6. Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. Apr 9 2010;86(4):551-9.
  7. Duro Friedl EA, Ferrari Mayans L, Desalvo Portal LN, Ferrari Ruiz P, Bidondo Horno MP, Astraldi Tellechea MM. Bruck syndrome: Osteogenesis imperfecta with congenital joint contractures. An Pediatr (Barc). Jul 2008;69(1):90-1.
  8.  Kellogg ND. Evaluation of suspected child physical abuse. Pediatrics. Jun 2007;119(6):1232-41..
  9. Forin V. Paediatric osteogenesis imperfecta: medical and physical treatment. Arch Pediatr. Jun 2008;15(5):792-3.
  10. Esposito P, Plotkin H. Surgical treatment of osteogenesis imperfecta: current concepts. Curr Opin Pediatr. Feb 2008;20(1):52-7.
  11. Salehpour S, Tavakkoli S. Cyclic pamidronate therapy in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab. Jan-Feb 2010;23(1-2):73-80.
  12. Rauch F, Munns C, Land C, Glorieux FH. Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation. J Clin Endocrinol Metab. Apr 2006;91(4):1268-74.
  13. Castillo H, Samson-Fang L. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol. Jan 2009;51(1):17-29.
  14. Bargman R, Huang A, Boskey AL, Raggio C, Pleshko N. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res. Apr 2010;51(2):123-31.
  15. Wekre LL, Frøslie KF, Haugen L, Falch JA. A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil. 2010;32(7):579-87.